Host Genotype and Gut Microbiome Modulate Insulin Secretion and Diet-Induced Metabolic Phenotypes

Cell Reports

Volumn 18, Issue 7, 2017, Pages 1739-1750

  Kreznar, Julia H ^a   Keller, Mark P ^a   Traeger, Lindsay L ^a   Rabaglia, Mary E ^a   Schueler, Kathryn L ^a   Stapleton, Donald S ^a   Zhao, Wen ^c   Vivas, Eugenio I ^a   Yandell, Brian S ^a,b   Broman, Aimee Teo ^c   Hagenbuch, Bruno ^d   Attie, Alan D ^a   Rey, Federico E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

gut microbiome; insulin secretion; metabolic disease; pancreatic islets

Indexed keywords

BILE ACID; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; DISEASE PREDISPOSITION; FAT INTAKE; FECAL MICROBIOTA TRANSPLANTATION; FOLLOW UP; GENETIC VARIATION; GENOTYPE; HOST; HYDROPHOBICITY; INSULIN RELEASE; INTESTINE FLORA; MALE; METABOLIC DISORDER; MICROBIAL METABOLISM; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; STRAIN DIFFERENCE; SUGAR INTAKE; TAXONOMY; ANIMAL; DIABETES MELLITUS; GASTROINTESTINAL TRACT; GENETICS; INSULIN RESISTANCE; LIPID DIET; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; BILE ACIDS AND SALTS; DIABETES MELLITUS; DIET, HIGH-FAT; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENETIC VARIATION; GENOTYPE; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICROBIOTA; PHENOTYPE;

EID: 85013156411     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2017.01.062     Document Type: Article

References (67)

1. Amyot, J., Semache, M., Ferdaoussi, M., Fontés, G., Poitout, V., Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-like receptor-4 and NF-κB signalling. PloS One, 7, 2012, e36200.
2. Aylor, D.L., Valdar, W., Foulds-Mathes, W., Buus, R.J., Verdugo, R.A., Baric, R.S., Ferris, M.T., Frelinger, J.A., Heise, M., Frieman, M.B., et al. Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Res. 21 (2011), 1213–1222.
3. Batta, A.K., Salen, G., Arora, R., Shefer, S., Batta, M., Person, A., Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J. Biol. Chem. 265 (1990), 10925–10928.
4. Benson, A.K., The gut microbiome-an emerging complex trait. Nat. Genet. 48 (2016), 1301–1302.
5. Bergström, A., Skov, T.H., Bahl, M.I., Roager, H.M., Christensen, L.B., Ejlerskov, K.T., Mølgaard, C., Michaelsen, K.F., Licht, T.R., Establishment of intestinal microbiota during early life: a longitudinal, explorative study of a large cohort of Danish infants. Appl. Environ. Microbiol. 80 (2014), 2889–2900.
6. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
7. Carmody, R.N., Gerber, G.K., Luevano, J.M. Jr., Gatti, D.M., Somes, L., Svenson, K.L., Turnbaugh, P.J., Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 17 (2015), 72–84.
8. Churchill, G.A., Airey, D.C., Allayee, H., Angel, J.M., Attie, A.D., Beatty, J., Beavis, W.D., Belknap, J.K., Bennett, B., Berrettini, W., et al., Complex Trait Consortium. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36 (2004), 1133–1137.
9. Clemente, J.C., Ursell, L.K., Parfrey, L.W., Knight, R., The impact of the gut microbiota on human health: an integrative view. Cell 148 (2012), 1258–1270.
10. Degnan, P.H., Taga, M.E., Goodman, A.L., Vitamin B12 as a modulator of gut microbial ecology. Cell Metab. 20 (2014), 769–778.
11. den Besten, G., van Eunen, K., Groen, A.K., Venema, K., Reijngoud, D.J., Bakker, B.M., The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54 (2013), 2325–2340.
12. Deutscher, J., Francke, C., Postma, P.W., How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 70 (2006), 939–1031.
13. Düfer, M., Hörth, K., Wagner, R., Schittenhelm, B., Prowald, S., Wagner, T.F., Oberwinkler, J., Lukowski, R., Gonzalez, F.J., Krippeit-Drews, P., Drews, G., Bile acids acutely stimulate insulin secretion of mouse β-cells via farnesoid X receptor activation and K(ATP) channel inhibition. Diabetes 61 (2012), 1479–1489.
14. Gao, Z., Yin, J., Zhang, J., Ward, R.E., Martin, R.J., Lefevre, M., Cefalu, W.T., Ye, J., Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58 (2009), 1509–1517.
15. Gauffin Cano, P., Santacruz, A., Moya, Á., Sanz, Y., Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PloS One, 7, 2012, e41079.
16. Goodman, A.L., McNulty, N.P., Zhao, Y., Leip, D., Mitra, R.D., Lozupone, C.A., Knight, R., Gordon, J.I., Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6 (2009), 279–289.
17. Handelsman, Y., Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 34 (2011), S244–S250.
18. Hartstra, A.V., Bouter, K.E., Bäckhed, F., Nieuwdorp, M., Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38 (2015), 159–165.
19. Hildebrandt, M.A., Hoffmann, C., Sherrill-Mix, S.A., Keilbaugh, S.A., Hamady, M., Chen, Y.Y., Knight, R., Ahima, R.S., Bushman, F., Wu, G.D., High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137 (2009), 1716–1724.
20. Houten, S.M., Watanabe, M., Auwerx, J., Endocrine functions of bile acids. EMBO J. 25 (2006), 1419–1425.
21. Islam, K.B.M.S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., Yokota, A., Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141 (2011), 1773–1781.
22. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., Nielsen, J., Bäckhed, F., Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
23. Kars, M., Yang, L., Gregor, M.F., Mohammed, B.S., Pietka, T.A., Finck, B.N., Patterson, B.W., Horton, J.D., Mittendorfer, B., Hotamisligil, G.S., Klein, S., Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 59 (2010), 1899–1905.
24. Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278 (2003), 9435–9440.
25. Kibirige, D., Mwebaze, R., Vitamin B12 deficiency among patients with diabetes mellitus: is routine screening and supplementation justified?. J. Diabetes Metab. Disord., 12, 2013, 17.
26. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., Bäckhed, F., From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165 (2016), 1332–1345.
27. Krishnaveni, G.V., Hill, J.C., Veena, S.R., Bhat, D.S., Wills, A.K., Karat, C.L., Yajnik, C.S., Fall, C.H., Low plasma vitamin B12 in pregnancy is associated with gestational ‘diabesity’ and later diabetes. Diabetologia 52 (2009), 2350–2358.
28. Kuipers, F., Bloks, V.W., Groen, A.K., Beyond intestinal soap—bile acids in metabolic control. Nat. Rev. Endocrinol. 10 (2014), 488–498.
29. Kumar, D.P., Rajagopal, S., Mahavadi, S., Mirshahi, F., Grider, J.R., Murthy, K.S., Sanyal, A.J., Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells. Biochem. Biophys. Res. Commun. 427 (2012), 600–605.
30. Lee, F.Y., Lee, H., Hubbert, M.L., Edwards, P.A., Zhang, Y., FXR, a multipurpose nuclear receptor. Trends Biochem. Sci. 31 (2006), 572–580.
31. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102 (2005), 11070–11075.
32. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71 (2005), 8228–8235.
33. Makishima, M., Okamoto, A.Y., Repa, J.J., Tu, H., Learned, R.M., Luk, A., Hull, M.V., Lustig, K.D., Mangelsdorf, D.J., Shan, B., Identification of a nuclear receptor for bile acids. Science 284 (1999), 1362–1365.
34. Martens, J.H., Barg, H., Warren, M.J., Jahn, D., Microbial production of vitamin B12. Appl. Microbiol. Biotechnol. 58 (2002), 275–285.
35. Mehrabian, M., Wen, P.Z., Fisler, J., Davis, R.C., Lusis, A.J., Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J. Clin. Invest. 101 (1998), 2485–2496.
36. Mehrabian, M., Castellani, L.W., Wen, P.Z., Wong, J., Rithaporn, T., Hama, S.Y., Hough, G.P., Johnson, D., Albers, J.J., Mottino, G.A., et al. Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei x C57BL/6J). J. Lipid Res. 41 (2000), 1936–1946.
37. Nguyen, A.T., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., Drucker, D.J., Lagrost, L., Grober, J., Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: involvement of the GLP-1 pathway. Diabetes 63 (2014), 471–482.
38. O'Connor, A., Quizon, P.M., Albright, J.E., Lin, F.T., Bennett, B.J., Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mamm. Genome 25 (2014), 583–599.
39. Ozcan, U., Yilmaz, E., Ozcan, L., Furuhashi, M., Vaillancourt, E., Smith, R.O., Görgün, C.Z., Hotamisligil, G.S., Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313 (2006), 1137–1140.
40. Parks, D.J., Blanchard, S.G., Bledsoe, R.K., Chandra, G., Consler, T.G., Kliewer, S.A., Stimmel, J.B., Willson, T.M., Zavacki, A.M., Moore, D.D., Lehmann, J.M., Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (1999), 1365–1368.
41. Parks, B.W., Nam, E., Org, E., Kostem, E., Norheim, F., Hui, S.T., Pan, C., Civelek, M., Rau, C.D., Bennett, B.J., et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 17 (2013), 141–152.
42. Perry, R.J., Peng, L., Barry, N.A., Cline, G.W., Zhang, D., Cardone, R.L., Petersen, K.F., Kibbey, R.G., Goodman, A.L., Shulman, G.I., Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature 534 (2016), 213–217.
43. Prawitt, J., Caron, S., Staels, B., Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr. Diab. Rep. 11 (2011), 160–166.
44. Priyadarshini, M., Villa, S.R., Fuller, M., Wicksteed, B., Mackay, C.R., Alquier, T., Poitout, V., Mancebo, H., Mirmira, R.G., Gilchrist, A., Layden, B.T., An acetate-specific GPCR, FFAR2, regulates insulin secretion. Mol. Endocrinol. 29 (2015), 1055–1066.
45. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., et al., MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
46. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
47. Renga, B., Mencarelli, A., Vavassori, P., Brancaleone, V., Fiorucci, S., The bile acid sensor FXR regulates insulin transcription and secretion. Biochim. Biophys. Acta 1802 (2010), 363–372.
48. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., Griffin, N.W., Lombard, V., Henrissat, B., Bain, J.R., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
49. Ridlon, J.M., Kang, D.-J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47 (2006), 241–259.
50. Roberts, A., Pardo-Manuel de Villena, F., Wang, W., McMillan, L., Threadgill, D.W., The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm. Genome 18 (2007), 473–481.
51. Russell, D.W., Fifty years of advances in bile acid synthesis and metabolism. J. Lipid Res. 50 (2009), S120–S125.
52. Ryan, K.K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H.E., Sandoval, D.A., Kohli, R., Bäckhed, F., Seeley, R.J., FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509 (2014), 183–188.
53. Sayin, S.I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., Bäckhed, F., Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 (2013), 225–235.
54. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
55. Setola, E., Monti, L.D., Galluccio, E., Palloshi, A., Fragasso, G., Paroni, R., Magni, F., Sandoli, E.P., Lucotti, P., Costa, S., et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur. J. Endocrinol. 151 (2004), 483–489.
56. Sommer, F., Bäckhed, F., The gut microbiota—masters of host development and physiology. Nat. Rev. Microbiol. 11 (2013), 227–238.
57. Tremaroli, V., Bäckhed, F., Functional interactions between the gut microbiota and host metabolism. Nature 489 (2012), 242–249.
58. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
59. Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
60. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
61. Ussar, S., Griffin, N.W., Bezy, O., Fujisaka, S., Vienberg, S., Softic, S., Deng, L., Bry, L., Gordon, J.I., Kahn, C.R., Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab. 22 (2015), 516–530.
62. Vatanen, T., Kostic, A.D., d'Hennezel, E., Siljander, H., Franzosa, E.A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T.D., Hämäläinen, A.M., et al., DIABIMMUNE Study Group. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165 (2016), 842–853.
63. Vrieze, A., Holleman, F., Zoetendal, E.G., de Vos, W.M., Hoekstra, J.B., Nieuwdorp, M., The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 53 (2010), 606–613.
64. Whitfield, C., Trent, M.S., Biosynthesis and export of bacterial lipopolysaccharides. Annu. Rev. Biochem. 83 (2014), 99–128.
65. Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61 (2010), 69–78.
66. Wu, M., McNulty, N.P., Rodionov, D.A., Khoroshkin, M.S., Griffin, N.W., Cheng, J., Latreille, P., Kerstetter, R.A., Terrapon, N., Henrissat, B., et al. Genetic determinants of in vivo fitness and diet responsiveness in multiple human gut Bacteroides. Science, 350, 2015, aac5992.
67. Zhang, Y., Lee, F.Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F.J., Willson, T.M., Edwards, P.A., Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc. Natl. Acad. Sci. USA 103 (2006), 1006–1011.